Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors

by on 17 de juny de 2024 with No hi ha comentaris
  • Peters, S., Angevin, E., Alonso-Gordoa, T., Rohrberg, K., Melero, I., Mellado, B., Perez-Gracia, J.L., Tabernero, J., . . . Steeghs, N. (2024). Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors. Clinical Cancer Research, 30(8), 1630-1641. https://doi.org/10.1158/1078-0432.ccr-23-2658

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *